Trauma care centres refer to a centre in the hospital that is equipped with specialized staff who can take care of trauma cases. The main objective of the trauma system is to provide the right service to the right patients. The main types of facilities provided by trauma care centres are in-house and standalone. The in-house trauma care centre services refer to a trauma care facility that is a specialized area within a hospital building. It is used to give special care to trauma patients. The different trauma injuries include falls, traffic-related injuries, stabs or wounds or cuts, burn injuries, brain injuries, and others. The various services provided by trauma care centres are inpatient, outpatient, and rehabilitation. The trauma care centres market research report is one of a series of new reports from The Business Research Company that provides trauma care centre market statistics, including Trauma care centres industry global market size, regional shares, competitors with a trauma care centre market share, detailed trauma care centre market segments, market trends and opportunities, and any further data you may need to thrive in the trauma care centres industry. This trauma care centres market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global trauma care centers market size grew from $20 billion in 2022 to $21.35 billion in 2023 at a compound annual growth rate (CAGR) of 6.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The trauma care centers market size is expected to grow to $26.44 billion in 2027 at a CAGR of 5.5%. The growing number of traumatic injury-related emergency department visits is expected to propel the growth of the trauma care centre market going forward. A traumatic injury refers to physical injuries that are sudden and severe in nature and which require immediate medical attention. The growing number of traumatic injury-related emergency department visits compels the trauma care centre market to provide better quality services for patients, which leads to an increase in the demand for trauma care centres. For instance, according to a report published by the Centers for Disease Control and Prevention, an American government agency, in 2022, there will be approximately 130 million visits to emergency departments in America, of which 35 million visits are related to various injuries. Furthermore, according to a journal article published by the National Library of Medicine, an American medical library, in 2021, there was an increase in penetration trauma from 10.3% to 13.0% in 2021. Therefore, the growing number of traumatic injury-related emergency department visits is driving the growth of the trauma care centre market. Technological advancements are key trends gaining popularity in the trauma care centre market. Many companies or hospitals operating in the trauma care centre market are focused on developing technologically advanced products to strengthen their market position and provide the best treatment for trauma patients. For instance, in November 2020, Johnson and Johnson Medtech, a US-based healthcare services and, technology company, introduced its new surgical robotic platform called Ottava. The new system is designed in such a way that it has six arms to provide more control and flexibility during surgery. In addition that this platform has a zero footprint design to enable patient access, increase space in the operating room, and improve the workflow. This system would help in the treatment of trauma patients more efficiently and effectively. According to the company, there are no robotic platforms available in the market which provides control and coordination across a full breadth of the procedure. In February 2022, Criticare Asia Hospitals, an Indian multi-specialty hospital, acquired Kohinoor hospital for an undisclosed amount. This acquisition would help Criticare become one of the most advanced multispecialty hospitals where Criticare would have three facilities in total which has 24 hours trauma care and other facilities along with a large number of medical staff to address all major and minor health issues. Kohinoor Hospital is an Indian multi-specialty hospital that provides a trauma care centre and various medical treatments. Major players in the trauma care centres market are University of Alabama Hospital, Banner University Medical Center Phoenix, St. Joseph's Hospital and Medical Center, Albany Medical Center, Ascension St. John Hospital, Baylor University Medical Center, Bellevue Hospital Center, Murnau Trauma Center, China Medical University Hospital, Gohealth Urgent Care, CityMD Urgent Care, Fastmed Urgent Care, Carenow Urgent Care, American Family Care, and Columbia Asia Hospitals. North America was the largest region in the trauma care centres market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the trauma care centres market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the trauma care centres market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The trauma care centre market includes revenues earned by providing services such as physical rehabilitation, mobility exercises, and gait exercises. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global trauma care centers market is segmented - 1) By Facility: In-house, Standalone 2) By Trauma: Falls, Traffic-Related Injuries, Stab or Wound or Cut, Burn Injury, Brain Injury, Other Injuries 3) By Service: Inpatient, Outpatient, Rehabilitation

The pain management devices and therapies manage chronic and critical pain in patients suffering from various conditions, such as cancer and neurological disorder. These are mainly used for spinal cord stimulation, sacral nerve stimulators, and deep brain stimulation. The main types of pain management devices and therapies are electrical stimulators, ablation devices, neurostimulators, and analgesic pumps. The various electrical stimulation devices include transcutaneous electrical nerve stimulation (TENS) devices, neuromuscular electrical stimulation (NMES/EMS) devices, combination devices, electrotherapy devices, and TNS, ablation devices include radiofrequency ablation devices, cryoablation devices and neurostimulation devices including spinal cord stimulation (SCS) devices, deep brain stimulation devices, vagus nerve stimulation devices, and sacral nerve stimulation devices. The analgesic infusion pumps covered in this market are intrathecal infusion pumps, and external infusion pumps that are used for neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and trauma applications. The pain management devices and therapies market research report is one of a series of new reports from The Business Research Company that provides pain management devices and therapies market statistics, including pain management devices and therapies industry global market size, regional shares, competitors with a pain management devices and therapies market share, detailed pain management devices and therapies market segments, market trends and opportunities, and any further data you may need to thrive in the pain management devices and therapies industry. This pain management devices and therapies market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pain management devices and therapies market grew from $4.01 billion in 2022 to $4.38 billion in 2023 at a compound annual growth rate (CAGR) of 9.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pain management devices and therapies market is expected to grow from $6.1 billion in 2027 at a CAGR of 8.6%. An increase in demand for pain management devices due rise in chronic diseases is driving the growth of the pain management devices and therapies market. Chronic diseases such as cancer, heart stroke often lead to unbearable pain in patients and thus creating a demand for pain management drugs and therapies. Chronic diseases persist over a long period and deteriorate the health of the patient. As reported in an article by the Brazilian Journal of Nephrology, around 60% of patients with chronic kidney disease reported pain of any kind of intensity, which required pain management drugs. Similarly, according to a report in the 'US National Library of Medicine, approximately 45% or 133 million of all Americans suffered from at least one chronic disease. It is also stated that more than two-thirds of all deaths are due to one of the chronic illnesses, which included coronary heart sickness, cancer, stroke, persistent obstructive pulmonary disease, and diabetes. This rise in chronic diseases is increasing the demand for pain management devices and therapies and driving the market. The availability of other alternatives to manage pain is restraining the growth of the pain management devices and therapies market. Alternatives treatment methods such as acupuncture, Marijuana treatment, dietary supplements, vitamins, etc. are being used instead of expensive pain relief devices and equipment. These alternative treatments may help with pain from bad backs, osteoarthritis, and headaches. For instance, the use of acupuncture works well for pain caused by many conditions, including fibromyalgia, osteoarthritis, back injuries, and sports injuries. Acupuncture is an ancient Chinese treatment that involves inserting thin pins through a person's skin at specific points on the body. Acupuncture comes with no prominent side effects and costs less compared to devices and equipment used to control pain. This rise in the use of alternative treatment methods is affecting the sales of pain management devices and therapies, and limiting the growth of the market. Companies in the pain management devices and therapies industry are focusing on the use of advanced technologies to cure chronic and acute pain without the use of any opioids (drugs). Special pain relief wearable devices are being developed by several companies that can be controlled manually or through a smartphone. These devices work by gathering neural pulses from the brain which triggers the release of the body's natural pain blocker. Thus, the devices electrically stimulate the nervous system and increase the body's resistance to pain. Companies such as NeuroMetrix, Sana, Oska wellness have introduced various types of wearable devices, ranging from a wearable mask, knee band, wrist band, etc. FDA has approved these devices as OTC (over-the-counter), which can be bought without a prescription. USFDA has defined the Pain Management Devices in section 882 under the medical devices market, under subchapter-H in Code of Federal Regulations (Title 21). Under these regulations, FDA requires the device manufacturers to register and list their devices with FDA and to follow general control requirements related to labeling, packaging, performance standards, and pre-market approval. To apply for premarket approval by FDA, the manufacturer is required to submit a premarket approval application that should include evidence providing reasonable assurance that the device is safe and effective. As per the FDA rule, the manufacturer can also submit a 510(k) notification demonstrating that the device is substantially equivalent to a device already on the market (a predicate device) that does not require a PMA. Major players in the pain management devices and therapies market are Abbott Laboratories, AstraZeneca, Pfizer, Boston Scientific Corporation, GlaxoSmithKline PLC., Teva Pharmaceutical Industries Ltd., Medtronic PLC., Novartis AG, Baxter International Inc., and Johnson & Johnson. North America was the largest region in the pain management devices and therapies market in 2022. Western Europe was the second largest region in the global pain management devices and therapies market report. The regions covered in the global pain management devices and therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the pain management devices and therapies market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The pain management devices and therapies market consists of sales of physical therapy, massage, acupuncture, osteopathic manipulative treatment (OMT) and chiropractic adjustments. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pain management devices and therapies market is segmented - 1) By Type: Electrical Stimulators, Ablation Devices, Neurostimulators, Analgesic Pumps 2) By Application: Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, Trauma 3) By Electrical Stimulation Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Combination Devices, Electrotherapy Devices, TNS 4) By Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices 5) By Analgesic Infusion Pumps: Intrathecal Infusion Pumps, External Infusion Pumps 6) By Neurostimulation Devices: Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices

Healthcare adhesive tape refers to pressure-sensitive tape that sticks and stays in place with firm pressure. They can be made from various materials, but most are breathable for comfort and ease of use. The healthcare adhesive tapes are used to offer the holding of a bandage or other dressing onto a wound. The main types of resins for healthcare adhesive tapes are acrylic, rubber, silicone, and other resin types. Acrylic healthcare adhesive tape is a resin-based, two-part adhesive, comprised of acrylic or methyl acrylic polymers. The various types of backing materials include paper, fabric, plastic, and other backing material types applied in surgery, wound dressing, splints, secure IV line, ostomy seal, hygiene, bandages, transdermal patches, blister protection, diagnostic, monitoring, medical devices, optical care, and others application. The healthcare adhesive tapes market research report is one of a series of new reports from The Business Research Company that provides healthcare adhesive tapes market statistics, including healthcare adhesive tapes industry global market size, regional shares, competitors with a healthcare adhesive tapes market share, detailed healthcare adhesive tapes market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare adhesive tapes industry. This healthcare adhesive tapes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global healthcare adhesive tapes market size grew from $34.11 billion in 2022 to $36.86 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The healthcare adhesive tapes market size is expected to grow to $49.61 billion in 2027 at a CAGR of 7.7%. The increasing number of accidental cases due to heavy trafficking is expected to propel the growth of the healthcare adhesive tape market going forward. Road traffic accidents are defined as collisions involving two or more objects on the road, one of which is a moving vehicle of any sort, and the other of which is a person. Healthcare adhesive tapes such as bandages, gauze, and other dressings are applied to the skin around such injuries occurred in accidents. For instance, in June 2022, according to World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, between 20 and 50 million people suffer non-fatal injuries, with many incurring a disability as a result of their injury due to a road traffic accident. Road traffic accidents take the lives of almost 1.3 million individuals annually. Therefore, an increasing number of accidental cases due to heavy traffic are driving the healthcare adhesive tape market. Product innovation is a key trend gaining popularity in the healthcare adhesive tapes market. Major companies operating in the healthcare adhesive tape market are focused on developing new products to strengthen their position in the healthcare adhesive tapes market. For instance, in April 2022, 3M Inc., a US-based medical devices company operating in the healthcare adhesive tapes market launched, 3M spun lace extended wear adhesive tape on the liner, 4576, a healthcare adhesive tape with a white spunlaced polyester nonwoven backing, coated with a unique pressure-sensitive acrylic adhesive used for longer wear applications, for up to 21 days. The innovative polyester nonwoven tape was developed for extended wear devices requiring attachment to the skin for up to a 21-day wear time. In December 2021, Boyd Corporation, a US-based pioneer of engineered materials and thermal management technologies, acquired MBK Tape Solutions for an undisclosed amount. Through this acquisition, Boyd Corporation aims to enhance its medical material science capabilities for applications such as biosensors, transdermal patches, and enhanced wound care. MBK Tape Solutions is a US-based manufacturer specializing in manufacturing medical adhesive tapes used for healthcare. Major players in the healthcare adhesive tapes market are 3M, Cardinal Health Inc., Nitto Denko Corporation, Johnson & Johnson Services Inc., Paul Hartmann AG, NICHIBAN Co. Ltd., Smith & Nephew, Lohmann GmbH & Co.KG, Avery Dennison Corporation, Medline Industries Inc., Essity Aktiebolag, Scapa Group PLC., Henkel Adhesives Technologies India Private Limited, tesa SE, and Parafix Tapes & Conversions Ltd. North America was the largest region in the healthcare adhesive tapes market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in healthcare adhesive tapes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the healthcare adhesive tapes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The healthcare adhesive tapes market consists of sales of adhesive transfer tapes, single coated tapes, double coated tapes, films & film tapes, foams & foam tapes, nonwovens &wovens, hydrogels & hydrocolloids and release liners. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global healthcare adhesive tapes market is segmented - 1) By Resin Type: Acrylic, Rubber, Silicone, Other Resin Types 2) By Backing Material Type: Paper, Fabric, Plastic, Other Backing Material Types 3) By Application: Surgery, Wound Dressing, Splints, Secure IV Line, Ostomy Seal, Hygiene, Bandages, Transdermal Patches, and Blister Protection, Diagnostic, Monitoring and Medical Devices, and Optical Care, Other Applications

Negative-pressure wound therapy (NPWT) is a therapeutic technique that uses a vacuum dressing to promote healing in acute or chronic wounds and enhances healing of second and third-degree burns. The negative pressure wound therapy (NPWT) research report is one of a series of new reports from The Business Research Company that provides negative pressure wound therapy (NPWT) statistics, including negative pressure wound therapy (NPWT) industry global market size, regional shares, competitors with negative pressure wound therapy (NPWT) shares, detailed negative pressure wound therapy (NPWT) segments, market trends and opportunities, and any further data you may need to thrive in the negative pressure wound therapy (NPWT) industry. This negative pressure wound therapy (NPWT) research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global negative pressure wound therapy (NPWT) market grew from $2.26 billion in 2022 to $2.39 billion in 2023 at a compound annual growth rate (CAGR) of 5.89%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The negative pressure wound therapy (NPWT) market size is expected to grow to $2.97 billion in 2027 at a CAGR of 5.64%. The growing prevalence of diabetes is expected to propel the growth of the negative pressure wound therapy market. Diabetic foot ulceration (DFU) is the most common application area of negative pressure wound therapy. A diabetic person's wounds are difficult to heal because people with uncontrolled diabetes may develop poor circulation, which results in less oxygenated circulation to the wound and the tissues do not heal as quickly. Thus, negative pressure wound therapy offers better graft take up than conventional dressing for diabetic patients. According to the International Diabetes Federation (IDF), in 2020, nearly 463 million people had diabetes in the world. The number of diabetic people in the Southeast Asia region is expected to increase from 88 million in 2020 to nearly 153 million by 2045. Therefore, the growing prevalence of diabetes drives the negative pressure wound therapy market. The growing technological advancements is a key trend gaining popularity in the negative pressure wound therapy market. Major companies operating in the negative pressure wound therapy market are focusing on developing technological solutions for negative pressure wound therapy. For example, in March 2020, Smith & Nephew, a UK-based medical equipment manufacturing company announced the launch of new PICO 14 Single Use Negative Pressure Wound Therapy System (sNPWT) which is helpful for high-risk surgical patients. This system has a pump duration of up to 14 days. These are helpful in reducing the risks of wound complications. In March 2021, Direct Healthcare Group, a UK based company offering pressure care solutions announced acquisition of Talley Group Ltd., for an undisclosed amount. This acquisition will help Direct Healthcare Group to strengthen its pressure ulcer prevention portfolio and also provide entry into the negative pressure wound therapy (NPWT) and intermittent pneumatic compression (IPC) therapy markets. Talley Group Ltd is a UK based based company offering products in electric bed frames, negative pressure wound therapy, IPC, and infection control. Major players in the negative pressure wound therapy market are Devon International Group, ConvaTec Group plc, DeRoyal Industries Inc., Smith & Nephew plc, Acelity L.P. Inc., Mölnlycke Health Care AB, ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health Inc., Talley Group Limited, Medela AG, Lohmann & Rauscher GmbH & Co. KG, TRIAGE MEDITECH PVT. LTD., Carilex Medical GmbH, Shandong Weigao Xinsheng Medical Devices Co. Lt, Genadyne Biotechnologies Inc., B. Braun Melsungen AG, Cork Medical LLC, BSN medical GmbH, Investor AB, Olle Larsson Holding AG, PAUL HARTMANN Asia-Pacific Ltd. and KCI Licensing Inc. North America was the largest region in the negative pressure wound therapy market in 2022. Asia-Pacific is the fastest growing region in the negative pressure wound therapy market. The regions covered in the negative pressure wound therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the negative pressure wound therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The negative-pressure wound therapy (NPWT) market consists of sales of conventional NPWT devices, disposable NPWT devices, and NPWT accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global negative pressure wound therapy market is segmented - 1) By Product: Conventional NPWT Devices, Single Use NPWT Devices 2) By Wound Type: Surgical And Traumatic Wounds, Ulcers, Burns 3) By End User: Hospitals, Homecare, Other End-Users

Wound debridement refers to the procedure of treating a wound in the skin by removing the dead skin from the wound. The debridement procedure helps in healthy tissue growth, minimizes scarring, and reduces the chances of infection. Depending on the wound, the type of debridement is selected on top of the form. Debridement can be done surgically or using non-surgical procedures such as the use of specific dressings and gels. The wound debridement helps to remove all the devitalized tissue from the wound bed and aid in faster wound healing. The main types of wound debridement are enzymatic debridement products, autolytic debridement products, gels, ointments, mechanical debridement products, ultrasonic debridement products, and others. Enzymatic wound debridement refers to the wound debridement method that uses highly selective natural occurring proteolytic enzymes manufactured by the industry. Enzymatic debridement products are used in removing necrotic material from partial-thickness wounds, pressure ulcers, and leg ulcers. The various wound types include venous leg ulcers, diabetic foot ulcers, pressure ulcers, surgical and traumatic wounds, burns, and others that are treated using several methods such as the surgical method, enzymatic method, mechanical method, autolytic method, and other methods. The several end-users include hospitals, clinics, and others. The wound debridement market research report is one of a series of new reports from The Business Research Company that provides wound debridement market statistics, including wound debridement industry global market size, regional shares, competitors with a wound debridement market share, detailed wound debridement market segments, market trends and opportunities, and any further data you may need to thrive in the wound debridement industry. This wound debridement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global wound debridement market size grew from $4.64 billion in 2022 to $5.04 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The wound debridement market size is expected to grow to $6.36 billion in 2027 at a CAGR of 6.0%. Growing awareness programs for wound care and management are expected to propel the growth of the wound debridement market going forward. There are various causes of wounds such as injury, accident, surgical wounds and burns, diabetes, vascular disease, and some chronic wounds, including leg ulcers, diabetic foot ulcers (DFUs), and pressure ulcers. Many wound management and prevention programs have been organized to create awareness about the severity of the wound. For instance, in June 2021, Healogics, a US-based company providing wound care services, launched the Healogics Wound Care Awareness Campaign from June 7–11, 2021, for a week to create awareness regarding the chronic wound healing program. This program is designed to help both patients and healthcare providers with resources and help improve health, heal wounds and prevent amputations. Many workshops have been arranged to create awareness about the wound’s severity and care. Therefore, the growing awareness programs for wound care and management are driving the growth of the wound debridement market. Technological innovations are a key trend gaining popularity in the wound debridement market. Major market players are concentrating their efforts on creating innovative technologies for wound debridement. Wound care has come a long way in recent years, with wearable technologies, electronic health data, and a diverse range of devices for examination and dressings alone. For example, in June 2021, researchers from RMIT University, an Australian-based university, developed a new type of nanosensor with a glowing feature wound dressing unit for advanced care to track and monitor infection. The antibacterial and anti-inflammatory properties of magnesium hydroxide have been harnessed in this unit, which aids in the reduction of inflammation, the struggle against germs, and the faster healing of wounds. In December 2021, Essity AB, a Sweden-based company that manufactures wound debridement products, acquired Hydrofera for a deal amount of USD 116 million. With this acquisition, Essity's strategic priority is to expand in medical solutions and offer advanced wound care, as well as strengthen its innovation capability and expand in this industry. Hydrofera is a US-based company that manufactures wound debridement products. Major players in the wound debridement market are Smith & Nephew, B. Braun Melsungen AG, Coloplast, ConvaTec, Lohmann & Rauscher, Integra Lifesciences, Arobella Medical LLC, Medline Industries, Acelity L.P. Inc., DeRoyal Industries, Histologics LLC, ArthoCare Corporation, Advanced Medical Solutions Group, Söring GmbH, Bactiguard AB, Zimmer Biomet, Monarch Labs, Lohmann & Rauscher International GmbH & Co. KG (L&R Group), Mölnlycke Healthcare, Advancis Medical, RLS Global, Sanara MedTech Inc., and EZ Debride. North America was the largest region in the wound debridement market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wound debridement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the wound debridement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The wound debridement market consists of sales of surgical debridement, enzymatic debridement, autolytic, and biological. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global wound debridement market is segmented - 1) By Product: Enzymatic Debridement Products, Autolytic Debridement Products, Gels, Ointments, Mechanical Debridement Products, Ultrasonic Debridement Products, Other Products 2) By Method: Surgical Method, Enzymatic Method, Mechanical Method, Autolytic Method, Other Methods 3) By Wound Type: Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical and Traumatic Wounds, Other Wound Types 4) By End User: Hospitals, Clinics, Other End Users

Wound care devices are used to prevent wound infections and promote wound healing. The main types of wound care devices are traditional adhesive dressings, negative-pressure wound therapy (NPWT), Traditional gauze dressings, and advanced wound care devices. Traditional wound dressing products including gauze, lint, plasters, bandages, and cotton wool are dry and used as primary or secondary dressings for protecting the wound from contaminations. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The wound care devices market research report is one of a series of new reports from The Business Research Company that provides wound care devices market statistics, including wound care devices industry global market size, regional shares, competitors with a wound care devices market share, detailed wound care devices market segments, market trends and opportunities, and any further data you may need to thrive in the wound care devices industry. This wound care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global wound care devices market grew from $55.05 billion in 2022 to $59.79 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The wound care devices market is expected to grow to $80.02 billion in 2027 at a CAGR of 7.6%. Combination dressings are increasingly being used to treat chronic wounds. The most widely used combination dressing is an antimicrobial agent and a biological material that together acts as a combination dressing. Combination dressings blend the chemical and physical properties of two or more types of wound dressing products to provide, waterproofing, anti-bacterial and viral infections, and skin-friendly capabilities. For instance, ConvaTec offers AQUACEL combination dressings that are made up of Hydrofiber Technology that incorporates offers stitch bonding functionality and increases the tensile strength of the dressing to be used as a combination dressing with an absorbent for the treatment of chronic wounds. Most widely used combination dressings include silver alginate dressings, silver collagen dressings, collagen hydrochloride dressings, and foam dressings. These dressings are used in the treatment of chronic ulcers, traumatic wounds, and surgical wounds. Wound care device manufacturers should consider focusing on delivering wound care products such as hydrocolloid dressings to improve treatment effectiveness and usage. Hydrocolloid dressing consists of adhesives with gel-forming components composed of either silicone or polyurethane. They are waterproof and self–adhering advanced wound care products that provide a moisture-filled healing environment for the wound. Hydrocolloid bandages are utilized for burns with moderate severity, and granular wounds and protect healed skin by absorbing moisture and swells. For instance, BenQ, a consumer electronics company, offers hydrocolloid dressing which is waterproof, invisible, and against UV rays facilitating high moisture absorption and wound healing. Major companies in the wound care devices market include Medtronic Inc., 3M Company, Smith & Nephew plc, Cardinal Health, Inc., ConvaTec Group Plc, Henry Schein, Inc., Paul Hartmann AG, Essity AB, Coloplast, and Integra Lifesciences. Asia-Pacific was the largest region in the global wound care devices market in 2022. North America was the second largest region in the global wound care devices market. Africa. was the smallest region in the global wound care devices market. The regions covered in the wound care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the wound care devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The wound care devices market consists of sales of instruments such as non-woven dressings, gauzes, hydrocolloids dressings, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global wound care devices market is segmented - 1) By Type: Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

String wound filter materials are depth cartridge filters that are constructed by weaving yarn around a core. String wound filter materials are commonly used to remove toxins and chemicals from various water sources. The main types of yarn in the string wound filter materials market include polypropylene, cotton, rayon, polyester, and others. The different core materials include polypropylene, stainless steel, others and are implemented in different verticals such as chemicals and petrochemicals, water and wastewater treatment, oil and gas, pharmaceuticals and medical, food and beverage, and others. The string wound Filter Materials market research report is one of a series of new reports from The Business Research Company that provides string wound Filter Materials market statistics, including string wound Filter Materials industry global market size, regional shares, competitors with a string wound Filter Materials market share, detailed string wound Filter Materials market segments, market trends and opportunities, and any further data you may need to thrive in the string wound Filter Materials industry. This string wound Filter Materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global string wound filter materials market size grew from $1.62 billion in 2022 to $1.74 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The string wound filter materials market size is expected to grow to $2.21 billion in 2027 at a CAGR of 6.1%. The increasing need for wastewater treatment is expected to fuel the growth of the string wound filter materials market in the forecast period. Wastewater treatment is the method of removing pollutants from wastewater or sewage and converting it to an effluent that can be added to the water supply with minimal environmental effects. String wound filter materials are prevalent and highly effective in wastewater treatment. String wound water filters are a form of depth filter that traps dirt not only on the surface but down to the center. For instance, according to a 2021-2022 report published by Water.org, a US-based non-profit organization for providing sanitation and safe water solutions, in the US, households without a water connection account for nearly 1.5 times the population. In order to fulfil their basic needs, 122 million people rely on surface water, like a river. Daily trips to collect water by millions of people. More than 30 minutes are regularly devoted by 282 million people. About 771 million Americans, or one in ten, do not have access to clean water. Therefore, the increasing need for wastewater treatment drives the growth of the string wound filter materials market. The growing technological advancements are a key trend gaining popularity in the string wound filter materials market. Major companies operating in the string wound filter materials sector are focused on developing technological solutions for string wound filter materials. For instance, Gopani, an Indian filter cartridge manufacturer is offering Clarywound 3X string wound filter cartridges that have three times the filtration efficiency of a regular wound filter cartridge. Clarywound 3X cartridges are made using a patented CNC machining process that creates a true multi-layered micronic gradient that spans five separate cartridges. In September 2021, Pentair plc, an Australia-based water treatment company signed a definitive agreement to acquire Pleatco for an undisclosed amount. With the acquisition of Pleatco, Pentair would have access to a wider selection of replacement filter products that can be offered through both Pleatco's and Pentair's current distribution channels for pools and spas. Pleatco is a US-based manufacturer of clean air and water filtration technology. Major players in the string wound filter materials market are Johns Manville, MMP Filtration, Shanghai Melko Filtration Co. Ltd., Coleman Filter Company, Delta Pure Filtration, Cleanflow Filter Solution, Eaton, Feature-Tec, Gopani Product Systems, Hongtek Filtration, and United Filters International (UFI). Asia-Pacific was the largest region in the string wound filter materials market in 2022. Asia-Pacific is expected to be the fastest-growing region in the market. The regions covered in the string wound filter materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the string wound filter materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The string wound filter materials market consists of sales of nylon and glass fiber. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global string wound filter materials market is segmented - 1) By Yarn Type: Polypropylene, Cotton, Rayon, Polyester, Other Yarn Types 2) By Core Material: Polypropylene, Stainless Steel, Other Core Materials 3) By End Use Industry: Chemicals And Petrochemicals, Water And Wastewater Treatment, Oil And gas, Pharmaceuticals And Medical, Food And Beverage, Other End Use Industries

Medical engineered materials refer to a material that is engineered to specific or custom requirements to engage with biological systems in a therapeutic or diagnostic manner for medical purposes. It is generally a link between science, technology, and medicine and is also known as biomaterials. The medical engineered materials are used to integrate key materials science modules with an understanding of medical design. The main types of medical engineered materials are medical plastics, medical foams, medical films, medical adhesives, and medical elastomers. Medical-grade plastic materials refer to plastics designed to make medical products. It is used for manufacturing products for in vitro diagnostics and primary packaging for pharmaceuticals, which preserves and contains medicines to avoid contamination. The various applications involved medical devices, medical disposables, medical wearables, and advanced wound care. The medical engineered materials market research report is one of a series of new reports from The Business Research Company that provides medical engineered materials market statistics, including medical engineered materials industry global market size, regional shares, competitors with a medical engineered materials market share, detailed medical engineered materials market segments, market trends and opportunities, and any further data you may need to thrive in the medical engineered materials industry. This medical engineered materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical engineered materials market size grew from $16.83 billion in 2022 to $19.3 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical engineered materials market size is expected to grow to $31.92 billion in 2027 at a CAGR of 13.4%. The increase in instances of chronic diseases are expected to drive the growth of the medical engineered materials market going forward. Chronic diseases refer to conditions that last a year or more and require ongoing medical attention or limit activities of daily living, or both. The nanoengineered parts can be used to build a miniature replica of a heart chamber and cure heart-related problems. For instance, in June 2020, according to the World Health Organization, a Switzerland-based government agency, chronic disease prevalence is expected to rise by 57% by the year 2020. Further, according to the International Diabetes Federation (IDF), an international organizations made from over 230 national diabetes association’s from 160 countries, in 2021, approximately 537 million adults were living with diabetes and the number is projected to increase to 643 million by 2030 and 783 million by 2045. Therefore, the increasing instances of chronic diseases are driving the growth of the medical engineered materials market. Product innovations are a key trend gaining popularity in the medical engineered materials market. Major companies operating in the market are introducing new innovative products such as polycarbonateresin which is based on certified renewablefeedstock, to sustain their position in the market. For instance,in March 2020, a US-based specialty chemicals company, introduced osteoconductive polyether ether ketone (PEEK) that enhances the union between bone and an implant. Biphasic calcium phosphate, a unique functional addition, was used to create the novel PEEK biomaterial's osteoconductive qualities, which enable bone cells to adhere to implants more quickly, positively and affecting fusion, or osteointegration, at the interface between the bone and the implant. In turn, this will hasten bone fusion and recovery. In February 2022, Celanese Corporation, a US-based global chemical leader, acquired Dupont's resins and Advanced Solutions business lines for an amount of $11 billion. This acquisition is expected to help Celanese build a market-leading portfolio with unrivalled scale, production power, and technological experience to serve the automotive, consumer, and industrial markets. DuPont is a US-based company operating in medical engineered materials. Major players in the medical engineered materials market are Evonik Industries AG, Covestro AG, BASF SE, Solvay S.A., SABIC, Trelleborg AB, Koninklijke DSM N.V., Celanese Corporation, DuPont de Nemours Inc., Ethicon Inc., Henkel AG & Co. KGaA, Huntsman Corporation, Momentive Performance Materials Inc., Nitto Denko Corporation, and Recticel. Asia-Pacific was the largest region in the medical engineered materials market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this medical engineered materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the medical engineered materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The medical engineered materials market consists of sales of medical plastics, medical foams, medical films, medical elastomers, and medical adhesives. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical engineered materials market is segmented - 1) By Type: Medical Plastics, Medical Foams, Medical Films, Medical Adhesives, Medical Elastomer 2) By Application Type: Medical Devices, Medical Disposables, Medical Wearables, Advanced Woundcare